瘤微环境在CLL病变发生过程中的作用
Alexander F Vom Stein1, Michael Hallek1, Phuong-Hien Nguyen1
1University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; Center for Molecular Medicine Cologne; CECAD Center of Excellence on Cellular Stress Responses in Aging-Associated Diseases, Cologne, Germany.
Seminars in hematology
|January 14, 2024
概括
慢性淋巴细胞白血病 (CLL) 细胞依赖于他们的瘤微环境 (TME). 这种相互作用促进了炎症,促进了CLL的存活,扩散和免疫逃避.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 慢性淋巴细胞白血病 (CLL) 细胞存活率和进展受到瘤微环境 (TME) 的严重影响.
- TME包括多种细胞组成部分,信号分子和细胞外囊泡,这些都是CLL病变的组成部分.
- 由CLL细胞和TME产生的慢性炎症环境在疾病发展中起着至关重要的作用.
研究的目的:
- 审查CLL细胞及其TME之间的多方面的相互作用.
- 阐明这些相互作用如何促进CLL的发病,包括生存,增殖和免疫逃避.
- 要突出了解CLL-TME相互作用的最新进展.
主要方法:
- 对CLL和TME相互作用现有研究的文献综述.
- 对研究的分析,研究了TME的细胞,分子和细胞外囊泡组成部分.
- 综合关于炎症和免疫逃避在CLL中的作用的发现.
主要成果:
- 结核细胞和TME共同创造一种促炎环境.
- 这种炎症环境促进了CLL细胞的存活和增殖.
- 这种CLL-TME相互作用促进了免疫规避,并影响了抗白血病监测.
结论:
- TME是CLL进展和行为的关键决定因素.
- 准CLL-TME相互作用有可能为新的治疗策略提供潜力.
- 需要进一步研究CLL-TME相互作用的复杂机制.
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Tumor Immunotherapy
527
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
527
T Cell Activation and Clonal Selection
739
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
739


